Vaccines. VI. Further advances in viral vaccines
Hottle, G.
Gaceta Medica de Mexico 111(4): 279-284
1976
ISSN/ISBN: 0016-3813 PMID: 939371 Document Number: 107171
Document emailed within 1 workday
Related Documents
Grado, C.; Contreras, G.; Suárez, M. 1977: I. Viral vaccines. Vaccines of common use Revista Chilena de Pediatria 48(2): 94-98Barinskiĭ, I.F.; Nesterchuk, S.L. 1995: Killed specific viral vaccines for therapeutic use in chronic viral infections Voprosy Virusologii 40(1): 5-8
Keith, J.A.; Agostini Bigger, L.; Arthur, P.A.; Maes, E.; Daems, R. 2013: Delivering the promise of the Decade of Vaccines: opportunities and challenges in the development of high quality new vaccines Vaccine 31(Suppl 2): B184-B193
Wegmann, A.; Glück, R.; Just, M.; Mischler, R.; Paroz, P.; Germanier, R. 1986: Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines Developments in Biological Standardization 65: 69-74
Prince, A.M.; Vnek, J. 1982: Hepatitis B vaccines. An evaluation of human plasma extracted vaccines Fortschritte der Medizin 100(40): 1839-1843
Crosnier 1962: Anti-poliomyelitis vaccinations. Live vaccines and inactivated vaccines. Respective indications. Current status of the problem Revue de Pathologie Generale et de Physiologie Clinique 62: 467-492
Clements, C.J.; Abdool-Karim, Q.; Chang, M.-L.; Nkowane, B.; Esparza, J. 2004: Breaking new ground--are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Vaccine 22(21-22): 2822-2826
Stehr, K.; Enders-Ruckle, G.; Spiess, H. 1975: Measles vaccination with split vaccines and living vaccines Münchener Medizinische Wochenschrift 117(27): 1159-1164
McMurray, D.N. 2000: Recent advances in improved tuberculosis vaccines Indian Journal of Pediatrics 67(2 Suppl): S58-S62
Patham, B.; Simmons, G.L.; Subramanya, S. 2011: Advances in dendritic cell-based vaccines for HIV Current Medicinal Chemistry 18(26): 3987-3994
Lu, F.; Zhuang, H. 1995: Advances in the research on nucleic acid vaccines Zhonghua Yu Fang Yi Xue Za Zhi 29(5): 303-304
Libwea, J.N.; Kobela, M.; Ollgren, J.; Emah, I.; Tchio, R.; Nohynek, H. 2014: Predictors to parental knowledge about childhood immunisation/EPi vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13) Pan African Medical Journal 17: 187
Petricciani, J. 2004: Are cancer vaccines really the same as infectious disease vaccines? Developments in Biologicals 116: 13-18
Krivorutchenko, I.L. 1999: Use of muramyl peptides in viral vaccines Voprosy Virusologii 44(1): 4-8
Melnick, J.L. 1989: Viral vaccines: achievements and challenges Acta Virologica 33(5): 482-493
van Gelder, P.; Makoschey, B. 2012: Production of viral vaccines for veterinary use Berliner und Munchener Tierarztliche Wochenschrift 125(3-4): 103-109
Aymard, M. 1996: Evaluation methodology of viral vaccines Therapie 51(4): 439-443
Di, W.; Wang, L.; Peng, T.; Wang, S.-Q. 2005: Advances in the study of antitumor vaccines with tumor-associated carbohydrate antigen Yao Xue Xue Bao 40(7): 591-599
Peetermans, J. 1996: Factors affecting the stability of viral vaccines Developments in Biological Standardization 87: 97-101
Gendon, I.Z. 2003: Mucosal viral vaccines: progress and problems Voprosy Virusologii 48(4): 4-10